Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New device may reduce bruising after heart procedure

NCT ID NCT01001663

Symptom relief Sponsor: Aarhus University Hospital Skejby Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a device called FemoSeal is safer and more comfortable than pressing on the groin by hand after a heart artery imaging test. About 1,000 adults having the test through the groin took part. The main goal was to see if the device led to fewer large bruises.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

1,005 people

The number who actually took part.

Start date

Sep 2009

Finished

Sep 2010

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The patient must be at least 18 years old * Patients undergoing femoral access coronary angiography * Patient must be competent for providing informed, written consent * Only 6F sheath Exclusion Criteria: * Percutaneous coronary intervention * Intra coronary measurements (FFR, IVUS, OCT, NIR) * Groin hematoma before closure * Pseudoaneurysm or AV fistula * Significant stenosis of ilial or femoral artery * Prior peripheral artery surgery * INR \> 3,0 * Platelet count \< 120 million per millilitre blood * Coagulopathy (bleeding disorder) * Thrombolysis in the last 24h * Planned heparin infusion after the procedure * Pregnancy * Uncontrolled hypertension \> 200 mmHg / 110 mmHg * Femoral access device closure in the last 30 days

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary angiography via femoral artery access are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary angiography via femoral artery access

Contacts and locations

Locations

  • Aarhus University Hospital Skejby

    Aarhus N, 8200, Denmark